Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. SC 13D/A Stake Beneficial Ownership Report
  5. 8-K Event Executive or director change
  6. DEF 14A Proxy Proxy Statement
  7. 4 Derivatives Options or other derivatives
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. 4 Open-market buy SVP and CHIEF INFORMATION OFF bought 600 shares at $0.35 ($210)
  10. 8-K Event Executive or director change
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. SC 13D/A Stake Beneficial Ownership Report
  19. SC 13D/A Stake Beneficial Ownership Report
  20. 4/A Open-market buy Director bought 510,000 shares at an average $0.34 ($173,500)

Page 49 of 77 · 1,525 filings